All royalties articles
-
BusinessMorphosys agrees to buy cancer epigenetics specialist Constellation
$1.7bn deal will be funded by selling rights to royalties on existing drugs
-
NewsEx-Harvard postdoc sues university for drug royalties
Former Harvard chemist says he lost out on millions after the technology he worked on was licensed to Merck & Co
-
BusinessHarvard settles with ex-student over drug royalties
Student claimed university forced him to accept unfair cut in patent deal